Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Benzarone is an active metabolite of the urate anion transporter 1 (URAT1) inhibitor benzbromarone (Item No. 19768).1,2 It inhibits URAT1 in Xenopus oocytes expressing the human enzyme (IC50 = 2.8 µM).2 Benzarone also inhibits the tyrosine phosphatase activity of eyes absent homolog 3 (EYA3; IC50 = 17.5 µM), as well as reduces the proliferation and migration of human umbilical vein endothelial cells (HUVECs) when used at a concentration of 7.5 µM.3 It uncouples oxidative phosphorylation in isolated rat liver mitochondria and induces apoptosis and necrosis in isolated rat hepatocytes.4 Benzarone (25 µg/g) reduces tumor growth in an A-673 Ewing sarcoma mouse xenograft model.5
WARNING This product is not for human or veterinary use.
1. Determination of benzbromarone, bromobenzarone and benzarone in plasma by gas chromatography—mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 224(2), 327-331 (1981).
2. Developing potent human uric acid transporter 1 (hURAT1) inhibitors. J. Med. Chem. 54(8), 2701-2713 (2011).
3. Structure-
4. Mechanisms of benzarone and benzbromarone-
5. Targeting EYA3 in ewing sarcoma retards tumor growth and angiogenesis. Mol. Cancer Ther. 20(5), 803-815 (2021).